Breast Cancer News and Research

Latest Breast Cancer News and Research

Inflammation plays key role in the metastasis of prostate cancer

Many would assume that "mounting an immune response" or "having your body fight the cancer" is a good thing.

19 Mar 2007

Protein podocalyxin changes the shape and adhesive quality of tumour cells

New non-toxic and targeted therapies for metastatic breast and ovarian cancers may now be possible, thanks to a discovery by a team of researchers at the University of British Columbia.

19 Mar 2007

Tykerb (lapatinib) - new anti-cancer treatment approved

The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).

14 Mar 2007

Interferon gamma identified as one of the signaling proteins involved with tumor relapse

Researchers at Virginia Commonwealth University's Massey Cancer Center studying the interaction between the immune system and cancer cells have identified interferon gamma as one of the signaling proteins involved with tumor relapse.

13 Mar 2007

Study aims to find which breast cancer patients need chemotherapy

Most postmenopausal women with small breast tumors don't need chemotherapy to reduce their recurrence risk after lumpectomy.

13 Mar 2007

University of Miami, Haitian Community health workers team up to address breast cancer

A collaboration between doctors at the University of Miami and members of the Haitian community in Southern Florida is attempting to address mammography screening and breast cancer among Haitian women living in the U.S., the Miami Herald reports.

11 Mar 2007

Computer key unlocks cancer, multiple sclerosis, and Alzheimer's disease

Danish and Belgian researchers have found a computer key that maps genes underlying heritable disorders, such as breast cancer, multiple sclerosis, and Alzheimer's disease. These results will possibly ease the discovery of new medicines and improve treatment in various disorders.

8 Mar 2007

ARIUS Research granted two new U.S. patents for antibodies

ARIUS Research has announced that it has been granted two new United States patents for antibodies within their CD63 program. Patent 7,175,846. covers anti-cancer antibodies in ARIUS' partnered program for melanoma, breast and prostate cancers and protects the valuable site on the disease target that the drug candidate binds to.

8 Mar 2007

Women from poor backgrounds fare worse with breast cancer

Women from more deprived backgrounds have worse treatment and a lower breast cancer survival rate than their more affluent counterparts - according to a new study published by Cancer Research UK in the British Journal of Cancer.

7 Mar 2007

Effect of depression in mothers with breast cancer on their children's concerns

A woman's breast cancer diagnosis can wreak as much havoc on her emotions as it does on her physical health. Mothers who experience bouts of depression during their battles with breast cancer may find that the effects reach beyond their own psyches to those of their children.

5 Mar 2007

Life-saving cancer genetic testing vastly underutilized

A study released today at the Society of Gynecologic Oncologists 38th Annual Meeting on Women's Cancer found few patients were aware of genetic cancer syndromes and the high risk of developing cancer if genetic mutations were found. Fewer still were motivated to follow up on this information with their own healthcare provider or genetic counseling/testing services.

5 Mar 2007

Obesity epidemic fuelling premature puberty in girls

Researchers in the United States say girls who are overweight at the age of three run the risk of reaching puberty as early as nine years old and warn that the obesity crisis is now affecting children's development.

5 Mar 2007

Industry funded studies on breast cancer treatments more likely to have positive results

Industry-funded clinical trials of breast cancer medications report more favorable results than nonindustry supported research, according to a study published in the Feb. 26 online edition of the journal Cancer, the New York Times reports (Bakalar, New York Times, 2/27).

28 Feb 2007

Cancer Research UK secures fenretinide orphan drug licence

A previously shelved drug could prove effective for treating a group of rare childhood cancers, and Cancer Research UK today announced it has been granted exclusive marketing rights for the drug in these indications by the European Commission and the Food and Drug Administration (FDA).

27 Feb 2007

Drug industry influences breast cancer research

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

27 Feb 2007

Stimuvax investigational lung cancer vaccine phase III study starts

Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).

26 Feb 2007